ArticleFrontiers in immunology2026
Deciphering the clinical and genetic spectrum of early-onset inborn errors of immunity in a Brazilian pediatric cohort.
Article in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Inborn errors of immunity are a heterogeneous group of rare genetic disorders associated with susceptibility to infections, autoimmunity, allergy, and malignancy. Owing to marked clinical variability, phenotypic overlap, and limited access to specialized diagnostic resources, their diagnosis remains challenging. To investigate the diagnostic contribution of whole-exome sequencing in this setting, we studied 100 Brazilian children up to 4 years of age with early-onset manifestations suggestive of inborn errors of immunity. Exome findings were classified as conclusive diagnoses, suggestive diagnoses, or alternative genetic diagnoses, according to variant pathogenicity and phenotype correlation. The cohort included children from 48 municipalities across Brazil, with a mean age of 16.7 ± 12.9 months at recruitment. A conclusive molecular diagnosis was established in 17% of cases. In this group, 21 disease-causing variants were identified, one-third of which were novel. Thirteen individuals had suggestive genetic findings, whereas five were diagnosed with conditions outside the inborn errors of immunity classification; in this latter group, two-thirds of the variants were novel. The most frequent category among conclusive diagnoses was combined immunodeficiencies with associated features or syndromes. Investigation of probands also led to the identification of 21 additional affected family members. Importantly, the molecular findings had a direct effect on clinical care, including the indication for hematopoietic stem cell transplantation in >50% of index cases with conclusive diagnoses, as well as implications for targeted treatment, genetic counseling, and reproductive planning. These findings demonstrate that whole-exome sequencing is a valuable diagnostic approach in children with early and complex presentations suggestive of inborn errors of immunity, while also contributing to genomic knowledge in an underrepresented population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.